Patents Assigned to AMIVAS, INC.
  • ARTESUNATE POWDERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURE
    Publication number: 20250339400
    Abstract: Disclosed herein are powders including a therapeutically effective amount of 4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]1exadecane-10-yl]oxy]butanoic acid (artesunate) or a pharmaceutically acceptable salt thereof that can be easily manufactured, sterilized and packaged. Processes for producing these powders and pharmaceutical compositions containing these powders are also disclosed.
    Type: Application
    Filed: July 11, 2025
    Publication date: November 6, 2025
    Applicant: AMIVAS, INC.
    Inventors: Bryan L. Smith, Lisa Thomas Read
  • ARTESUNATE POWDERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURE
    Publication number: 20250262184
    Abstract: Disclosed herein are powders including a therapeutically effective amount of 4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]1exadecane-10-yl]oxy]butanoic acid (artesunate) or a pharmaceutically acceptable salt thereof that can be easily manufactured, sterilized and packaged. Processes for producing these powders and pharmaceutical compositions containing these powders are also disclosed.
    Type: Application
    Filed: October 7, 2024
    Publication date: August 21, 2025
    Applicant: AMIVAS, INC.
    Inventors: Bryan L. Smith, Lisa Thomas Read
  • Artesunate powders, pharmaceutical compositions and methods of manufacture
    Patent number: 12390442
    Abstract: Disclosed herein are powders including a therapeutically effective amount of 4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]1exadecane-10-yl]oxy]butanoic acid (artesunate) or a pharmaceutically acceptable salt thereof that can be easily manufactured, sterilized and packaged. Processes for producing these powders and pharmaceutical compositions containing these powders are also disclosed.
    Type: Grant
    Filed: October 7, 2024
    Date of Patent: August 19, 2025
    Assignee: AMIVAS, INC.
    Inventors: Bryan L. Smith, Lisa Thomas Read
  • Artesunate powders, pharmaceutical compositions and methods of manufacture
    Patent number: 12121506
    Abstract: Disclosed herein are powders including a therapeutically effective amount of 4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]1exadecane-10-yl]oxy]butanoic acid (artesunate) or a pharmaceutically acceptable salt thereof that can be easily manufactured, sterilized and packaged. Processes for producing these powders and pharmaceutical compositions containing these powders are also disclosed.
    Type: Grant
    Filed: February 16, 2024
    Date of Patent: October 22, 2024
    Assignee: AMIVAS, INC.
    Inventors: Bryan L. Smith, Lisa Thomas Read